1
Total investments
0
Early stage
0
Mid stage
0
Late stage
5y
Years active
Portfolio
0 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
No investments found
Experience · 2 entries
All (2)
Investments (1)
2024
Associate Director
Jan 2024
At Regeneron we believe that when the right idea finds the right team, powerful change is possible. As we work across our expanding global network to invent, develop and commercialize life-transforming medicines for people with serious diseases, we’re establishing new ways to think about science, manufacturing and commercialization. And new ways to think about health. Connect with us so we can learn more about you, and you can learn more about our biopharmaceutical medicines. And join us, as we build a future we believe in.
Please visit www.regeneron.com/social-media-terms for information on how to engage with us on social media.
An important note about privacy: Regeneron is committed to your privacy and will not ask for sensitive personal information such as social security number, date of birth or bank account details via email or social media.
2021
Seed Investor / Business Angel
May 2021
Europe’s number one Business Angel Network for Health
Angles Santé investors provide their funds and expertise to start-ups with strong potential to support their launch and development.
Our mission at Angels Santé: to detect European start-ups that meet the challenges of our health systems with economically responsible solutions and strong medical benefits, to boost seed-stage development by providing direct capital, expertise and networks, to mobilize non-specialized investors towards health investment to meet the needs of ambitious projects.
Our members invest in healthcare projects that they understand, thanks to their expertise and that they believe in.
Their goal is twofold: to raise awareness and accountability in a changing health system by investing in innovative solutions which seek to address present and future medico-economic challenges and to finance projects that are too innovative for some.
